These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34092048)

  • 1. Apparent treatment-resistant hypertension among ambulatory hypertensive patients: a cross-sectional study from 13 general hospitals.
    Kim S; Park JJ; Shin MS; Kwak CH; Lee BR; Park SJ; Lee HY; Kim SH; Kang SM; Yoo BS; Chung JW; Choi SW; Jo SH; Shin J; Choi DJ
    Korean J Intern Med; 2021 Jul; 36(4):888-897. PubMed ID: 34092048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment resistant hypertension among ambulatory hypertensive patients: A cross sectional study.
    Asgedom SW; Amanuel K; Gidey MT; Niriayo YL; Gidey K; Atey TM
    PLoS One; 2020; 15(4):e0232254. PubMed ID: 32343723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
    BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Newell J; Murphy AW
    Br J Gen Pract; 2018 Jun; 68(671):e394-e400. PubMed ID: 29739776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly.
    Kaboré J; Metzger M; Helmer C; Berr C; Tzourio C; Massy ZA; Stengel B
    PLoS One; 2016; 11(1):e0146056. PubMed ID: 26807712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor sleep quality and resistant hypertension.
    Bruno RM; Palagini L; Gemignani A; Virdis A; Di Giulio A; Ghiadoni L; Riemann D; Taddei S
    Sleep Med; 2013 Nov; 14(11):1157-63. PubMed ID: 23993872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.
    Veglio F; Rabbia F; Riva P; Martini G; Genova GC; Milan A; Paglieri C; Carra R; Chiandussi L
    Clin Exp Hypertens; 2001 Apr; 23(3):203-11. PubMed ID: 11339687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.
    Siddiqui M; Dudenbostel T; Calhoun DA
    Can J Cardiol; 2016 May; 32(5):603-6. PubMed ID: 26514749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent treatment-resistant hypertension among elderly Korean hypertensives: an insight from the HIT registry.
    Choi SW; Kim MK; Han SW; Han SH; Lee BK; Lee SU; Hur SH; Lim SW; Moon KW; Lee SG; Lee SH; Oh SK; Chea JG; Joo SJ; Jo MC; Hong KS; Ryu KH;
    J Hum Hypertens; 2014 Mar; 28(3):201-5. PubMed ID: 23985877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.
    Romano S; Idolazzi C; Fava C; Fondrieschi L; Celebrano M; Delva P; Branz L; Donato A; Dalbeni A; Minuz P
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):295-301. PubMed ID: 29959696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of blood pressure control in hypertensive stroke survivors: an ambulatory blood pressure monitoring study.
    Zakopoulos N; Spengos K; Tsivgoulis G; Zis V; Manios E; Vemmos K
    Blood Press Monit; 2006 Oct; 11(5):235-41. PubMed ID: 16932032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of target organ damage and metabolic abnormalities in resistant hypertension].
    Armario P; Oliveras A; Hernández Del Rey R; Ruilope LM; De La Sierra A;
    Med Clin (Barc); 2011 Oct; 137(10):435-9. PubMed ID: 21719041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.